Showing results (141-150 of 269) with videos related to
Sort By:
Pageof 27
Journal of Virology|January 8, 2016
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesEve-Isabelle Pécheur, Viktoriya Borisevich, Peter Halfmann, et al.Journal of Virology|July 28, 2010
Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primatesThomas W Geisbert, Michael Bailey, Joan B Geisbert, et al.The Journal of Infectious Diseases|October 31, 2019
A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green MonkeysAbhishek N Prasad, Krystle N Agans, Satheesh K Sivasubramani, et al.The Journal of Clinical Investigation|July 14, 2015
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesMichelle Meyer, Tania Garron, Ndongala M Lubaki, et al.The Journal of Infectious Diseases|September 18, 2016
Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From BloodJason W Benzine, Kerry M Brown, Krystle N Agans, et al.Plos Pathogens|January 24, 2007
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeysWendelien B Oswald, Thomas W Geisbert, Kelly J Davis, et al.Journal of Virology|September 16, 2006
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccineKathleen M Daddario-DiCaprio, Thomas W Geisbert, Joan B Geisbert, et al.Immunogenetics|October 11, 2005
Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoproteinChris Druar, Surinder S Saini, Meredith A Cossitt, et al.The Journal of Infectious Diseases|December 6, 2007
In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent proteinHideki Ebihara, Steven Theriault, Gabriele Neumann, et al.Scientific Reports|October 13, 2015
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onsetDavid Safronetz, Kyle Rosenke, Jonna B Westover, et al.Pageof 27